US Patent 11931354 Formulations of oxabicycloheptanes and oxabicycloheptenes

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

119313540

Patent Inventor Names

Mickey L. Wells0

John S. Kovach0

Date of Patent

March 19, 2024

Patent Application Number

167056990

Date Filed

December 6, 2019

Patent Citations

‌

US Patent 8058268 Neuroprotective agents for the prevention and treatment of neurodegenerative diseases

‌

US Patent 8455668 Method for preparing hydroxymethylfurfural

‌

US Patent 8455688 HDAC inhibitors

‌

US Patent 8541458 Oxabicycloheptanes and oxabicycloheptenes, their preparation and use

‌

US Patent 8609089 Compositions of PD-1 antagonists and methods of use

‌

US Patent 8685436 Use of hydroxyflavanones for masking bitter taste

‌

US Patent 8697845 Antibodies specifically directed to a soluble form of CTLA-4

‌

US Patent 8822461 Oxabicycloheptanes and oxabicycloheptenes, their preparation and use

...

Patent Primary Examiner

CPC Code

...

Patent abstract

The invention relates to a pharmaceutical composition comprising a protein phosphatase 2A (PP2A) inhibitor and monosodium glutamate.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11931354 Formulations of oxabicycloheptanes and oxabicycloheptenes

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11931354 Formulations of oxabicycloheptanes and oxabicycloheptenes